Agency Information Collection Activities; Proposed Collection; Comments Requested; Extension With Change of a Previously Approved Collection: National Drug Threat Survey, 36582 [2013-14347]
Download as PDF
<![CDATA[
36582
Federal Register / Vol. 78, No. 117 / Tuesday, June 18, 2013 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0052]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested; Extension With
Change of a Previously Approved
Collection: National Drug Threat
Survey
mstockstill on DSK4VPTVN1PROD with NOTICES
ACTION:
30-Day Notice.
The United States Department of
Justice (DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 78, Number 64, page
20141 on April 3, 2013, allowing for a
60 day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until July 18, 2013. This
process is conducted in accordance with
5 CFR 1320.10.
If you have comments especially on
the estimated public burden and
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Richard L. Nagy, Unit
Chief, Domestic Strategic Intelligence
Unit, Office of Intelligence, Warning,
Plans and Programs, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency whether the
information will have practical utility;
• Evaluate the accuracy of the
agencies’ estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
VerDate Mar<15>2010
16:52 Jun 17, 2013
Jkt 229001
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection 1117–0052
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
National Drug Threat Survey.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Form number: None.
Component: Intelligence Division,
Drug Enforcement Administration, U.S.
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Federal, State, Tribal, and
Local, law enforcement agencies.
Other: None.
Abstract: This survey is a critical
component of the National Drug Threat
Assessment and other reports and
assessments produced by the Drug
Enforcement Administration. It provides
direct access to detailed drug threat data
from state and local law enforcement
agencies.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that
approximately 3,500 respondents will
complete a survey response within
approximately 20 minutes.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 1,167
total annual burden hours associated
with this collection.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
Department of Justice, Two Constitution
Square, 145 N Street NE., Suite 3W–
1407B, Washington, DC 20530.
Dated: June 12, 2013.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2013–14347 Filed 6–17–13; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 12–15]
Belinda R. Mori, N.P.; Decision and
Order
On November 17, 2011, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Belinda R. Mori, N.P.
(Respondent), of Santa Fe, New Mexico.
The Show Cause Order proposed the
denial of Respondent’s pending
application for a DEA Certificate of
Registration, on the ground that her
‘‘registration would be inconsistent with
the public interest.’’ ALJ Ex. 1, at 1.
The Show Cause Order specifically
alleged that on March 18, 2011,
Respondent applied for a Certificate of
Registration as a mid-level practitioner,
seeking authority to dispense controlled
substances in schedules II through V. Id.
The Order further alleged that
Respondent had previously held a
registration, which authorized her to
dispense controlled substances in
schedules II through V as a mid-level
practitioner but that ‘‘this registration
expired on January 31, 2011.’’ Id.
Next, the Show Cause Order alleged
that ‘‘[b]etween August 29, 2009 and
March 15, 2011, [Respondent] issued
approximately thirty-three purported
prescriptions for alprazolam (a
[s]chedule IV controlled substance) to
[her] daughter without conducting a
medical examination and without
creating a patient record,’’ and that
these prescriptions ‘‘were issued outside
the usual course of professional
practice, in violation of Federal and . . .
state law.’’ Id. (citing 21 CFR 1306.04(a);
N.M Admin. Code tit. 16, §§ 12.2.7(V)
and 12.2.13(N)(5)(g)). The Order further
alleged that ‘‘[o]n or about March 15,
2011, [Respondent] issued a purported
prescription for alprazolam . . . to [her]
daughter . . . while [she was] without
a valid DEA Certificate of Registration,
in violation of Federal and . . . state
law.’’ Id. at 2 (citing 21 U.S.C. 841(a)(1);
N.M. Admin. Code tit. 16,
§ 12.2.13(N)(5)(a)).
On December 5, 2011, Respondent,
through her counsel, requested a
hearing on the allegations. ALJ Ex. 2.
The matter was placed on the docket of
the Office of Administrative Law Judges
(ALJ), and assigned to an ALJ who
proceeded to conduct pre-hearing
procedures.
On December 20, 2011, the
Government filed its pre-hearing
statement. Therein, the Government
provided notice that it intended to elicit
E:\FR\FM\18JNN1.SGM
18JNN1
]]>Agencies
[Federal Register Volume 78, Number 117 (Tuesday, June 18, 2013)]
[Notices]
[Page 36582]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14347]
[[Page 36582]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0052]
Agency Information Collection Activities; Proposed Collection;
Comments Requested; Extension With Change of a Previously Approved
Collection: National Drug Threat Survey
ACTION: 30-Day Notice.
-----------------------------------------------------------------------
The United States Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995. The proposed information collection is published to obtain
comments from the public and affected agencies. This proposed
information collection was previously published in the Federal Register
Volume 78, Number 64, page 20141 on April 3, 2013, allowing for a 60
day comment period.
The purpose of this notice is to allow for an additional 30 days
for public comment until July 18, 2013. This process is conducted in
accordance with 5 CFR 1320.10.
If you have comments especially on the estimated public burden and
associated response time, suggestions, or need a copy of the proposed
information collection instrument with instructions or additional
information, please contact Richard L. Nagy, Unit Chief, Domestic
Strategic Intelligence Unit, Office of Intelligence, Warning, Plans and
Programs, Drug Enforcement Administration, 8701 Morrissette Drive,
Springfield, VA 22152.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency
whether the information will have practical utility;
Evaluate the accuracy of the agencies' estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used;
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Overview of This Information Collection 1117-0052
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: National Drug Threat Survey.
(3) Agency form number, if any, and the applicable component of the
Department sponsoring the collection:
Form number: None.
Component: Intelligence Division, Drug Enforcement Administration,
U.S. Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Federal, State, Tribal, and Local, law enforcement
agencies.
Other: None.
Abstract: This survey is a critical component of the National Drug
Threat Assessment and other reports and assessments produced by the
Drug Enforcement Administration. It provides direct access to detailed
drug threat data from state and local law enforcement agencies.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: It is estimated
that approximately 3,500 respondents will complete a survey response
within approximately 20 minutes.
(6) An estimate of the total public burden (in hours) associated
with the collection: There are an estimated 1,167 total annual burden
hours associated with this collection.
If additional information is required contact: Jerri Murray,
Department Clearance Officer, Policy and Planning Staff, Justice
Management Division, Department of Justice, Two Constitution Square,
145 N Street NE., Suite 3W-1407B, Washington, DC 20530.
Dated: June 12, 2013.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2013-14347 Filed 6-17-13; 8:45 am]
BILLING CODE 4410-09-P
